{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:46:28Z","timestamp":1788047188438,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T00:00:00Z","timestamp":1278374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00011-010-0229-x","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T14:11:01Z","timestamp":1278339061000},"page":"1091-1097","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis"],"prefix":"10.1007","volume":"59","author":[{"given":"Weiping","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Markel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,6]]},"reference":[{"key":"229_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2106\/00004623-200202000-00002","volume":"84","author":"DJ Berry","year":"2002","unstructured":"Berry DJ, Harmsen WS, Cabanela ME, Morrey BF. Twenty-five-year survivorship of two thousand consecutive primary charnley total hip replacements : factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg Am. 2002;84:171\u20137.","journal-title":"J Bone Joint Surg Am"},{"key":"229_CR2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2106\/00004623-200306000-00013","volume":"85-A","author":"JD Keener","year":"2003","unstructured":"Keener JD, Callaghan JJ, Goetz DD, et al. Twenty-five-year results after Charnley total hip arthroplasty in patients less than fifty\u00a0years old: a concise follow-up of a previous report. J Bone Joint Surg Am. 2003;85-A:1066\u201372.","journal-title":"J Bone Joint Surg Am"},{"key":"229_CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1302\/0301-620X.81B4.9859","volume":"81","author":"D Fender","year":"1999","unstructured":"Fender D, Harper WM, Gregg PJ. Outcome of Charnley total hip replacement across a single health region in England: the results at five\u00a0years from a regional hip register [see comments]. J Bone Joint Surg Br. 1999;81:577\u201381.","journal-title":"J Bone Joint Surg Br"},{"key":"229_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1243\/0954411001535219","volume":"214","author":"E Ingham","year":"2000","unstructured":"Ingham E, Fisher J. Biological reactions to wear debris in total joint replacement. Proc Inst Mech Eng [H]. 2000;214:21\u201337.","journal-title":"Proc Inst Mech Eng [H]"},{"key":"229_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0736-0266(01)00070-5","volume":"20","author":"EM Greenfield","year":"2002","unstructured":"Greenfield EM, Bi Y, Ragab AA, et al. The role of osteoclast differentiation in aseptic loosening. J Orthop Res. 2002;20:1\u20138.","journal-title":"J Orthop Res"},{"key":"229_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9440(10)65266-2","volume":"154","author":"KD Merkel","year":"1999","unstructured":"Merkel KD, Erdmann JM, McHugh KP, et al. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol. 1999;154:203\u201310.","journal-title":"Am J Pathol"},{"key":"229_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1163\/156856299X00162","volume":"10","author":"S Stea","year":"1999","unstructured":"Stea S, Visentin M, Granchi D, et al. Wear debris and cytokine production in the interface membrane of loosened prostheses. J Biomater Sci Polym Ed. 1999;10:247\u201357.","journal-title":"J Biomater Sci Polym Ed"},{"key":"229_CR8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2106\/00004623-199509000-00002","volume":"77","author":"WJ Maloney","year":"1995","unstructured":"Maloney WJ, Smith RL, Schmalzried TP, et al. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am. 1995;77:1301\u201310.","journal-title":"J Bone Joint Surg Am"},{"key":"229_CR9","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0142-9612(03)00056-5","volume":"24","author":"RK Sethi","year":"2003","unstructured":"Sethi RK, Neavyn MJ, Rubash HE, Shanbhag AS. Macrophage response to cross-linked and conventional UHMWPE. Biomaterials. 2003;24:2561\u201373.","journal-title":"Biomaterials"},{"key":"229_CR10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.gt.3302202","volume":"11","author":"PH Wooley","year":"2004","unstructured":"Wooley PH, Schwarz EM. Aseptic loosening. Gene Ther. 2004;11:402\u20137.","journal-title":"Gene Ther"},{"issue":"Suppl 1","key":"229_CR11","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.5435\/00124635-200800001-00015","volume":"16","author":"EM Schwarz","year":"2008","unstructured":"Schwarz EM. What potential biologic treatments are available for osteolysis? J Am Acad Orthop Surg. 2008;16(Suppl 1):S72\u20135.","journal-title":"J Am Acad Orthop Surg"},{"key":"229_CR12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2106\/00004623-200107000-00012","volume":"83-A","author":"PF Pollice","year":"2001","unstructured":"Pollice PF, Rosier RN, Looney RJ, et al. Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes: a potential treatment for aseptic loosening of total joint components. J Bone Joint Surg Am. 2001;83-A:1057\u201361.","journal-title":"J Bone Joint Surg Am"},{"key":"229_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1359\/jbmr.2001.16.2.338","volume":"16","author":"LM Childs","year":"2001","unstructured":"Childs LM, Goater JJ, O\u2019Keefe RJ, Schwarz EM. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res. 2001;16:338\u201347.","journal-title":"J Bone Miner Res"},{"key":"229_CR14","first-page":"4253","volume":"21","author":"J Yatsunami","year":"2001","unstructured":"Yatsunami J, Hayashi S. Fourteen-membered ring macrolides as anti-angiogenic compounds. Anticancer Res. 2001;21:4253\u20138.","journal-title":"Anticancer Res"},{"key":"229_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/000164801300006326","volume":"121","author":"A Cervin","year":"2001","unstructured":"Cervin A. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol. 2001;121:83\u201392.","journal-title":"Acta Otolaryngol"},{"key":"229_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","volume":"31","author":"EJ Giamarellos-Bourboulis","year":"2008","unstructured":"Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int J Antimicrob Agents. 2008;31:12\u201320.","journal-title":"Int J Antimicrob Agents"},{"key":"229_CR17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000195915","volume":"58","author":"H Nagai","year":"1991","unstructured":"Nagai H, Shishido H, Yoneda R, et al. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration. 1991;58:145\u20139.","journal-title":"Respiration"},{"key":"229_CR18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/thx.52.10.915","volume":"52","author":"H Koyama","year":"1997","unstructured":"Koyama H, Geddes DM. Erythromycin and diffuse panbronchiolitis. Thorax. 1997;52:915\u20138.","journal-title":"Thorax"},{"key":"229_CR19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","volume":"157","author":"S Kudoh","year":"1998","unstructured":"Kudoh S, Azuma A, Yamamoto M, et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med. 1998;157:1829\u201332.","journal-title":"Am J Respir Crit Care Med"},{"key":"229_CR20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000196514","volume":"63","author":"O Sakito","year":"1996","unstructured":"Sakito O, Kadota J, Kohno S, et al. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration. 1996;63:42\u20138.","journal-title":"Respiration"},{"key":"229_CR21","first-page":"524","volume":"37","author":"GA Dette","year":"1987","unstructured":"Dette GA, Knothe H, Kellner HM. Whole body tissue distribution of [14C]-erythromycin in the guinea pig. an autoradiographic study. Arzneimittelforschung. 1987;37:524\u20137.","journal-title":"Arzneimittelforschung"},{"key":"229_CR22","first-page":"167","volume":"57","author":"AM Cuffini","year":"1989","unstructured":"Cuffini AM, Tullio V, Cimino F, Carlone NA. Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 1. Uptake of 3H-macrolides by human macrophages. Microbios. 1989;57:167\u201378.","journal-title":"Microbios"},{"key":"229_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0736-0266(03)00130-X","volume":"22","author":"WP Ren","year":"2004","unstructured":"Ren WP, Li XY, Chen BD, Wooley PH. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NFkB activity. J Orthop Res. 2004;22:21\u20139.","journal-title":"J Orthop Res"},{"key":"229_CR24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jor.20004","volume":"24","author":"WP Ren","year":"2006","unstructured":"Ren WP, Bin W, Mayton L, Wooley PH. Erythromycin (EM) inhibits wear debris-induced inflammatory osteolysis in a murine model. J Orthop Res. 2006;24:280\u201390.","journal-title":"J Orthop Res"},{"key":"229_CR25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bone.2008.12.015","volume":"44","author":"W Ren","year":"2009","unstructured":"Ren W, Blasier R, Peng X, et al. Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. Bone. 2009;44:671\u20137.","journal-title":"Bone"},{"key":"229_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0883-5403(06)80157-9","volume":"6","author":"PK Stephenson","year":"1991","unstructured":"Stephenson PK, Freeman MA, Revell PA, et al. The effect of hydroxyapatite coating on ingrowth of bone into cavities in an implant. J Arthroplasty. 1991;6:51\u20138.","journal-title":"J Arthroplasty"},{"key":"229_CR27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00003086-200111000-00058","volume":"392","author":"B Karabatsos","year":"2001","unstructured":"Karabatsos B, Myerthall SL, Fornasier VL, et al. Osseointegration of hydroxyapatite porous-coated femoral implants in a canine model. Clin Orthop Relat Res. 2001;392:442\u20139.","journal-title":"Clin Orthop Relat Res"},{"key":"229_CR28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.knee.2008.01.013","volume":"15","author":"U Hansson","year":"2008","unstructured":"Hansson U, Ryd L, Toksvig-Larsen S. A randomised RSA study of Peri-Apatite HA coating of a total knee prosthesis. Knee. 2008;15:211\u20136.","journal-title":"Knee"},{"key":"229_CR29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jbm.b.30110","volume":"71","author":"R Zhang","year":"2004","unstructured":"Zhang R, An Y, Toth CA, et al. Osteogenic protein-1 enhances osseointegration of titanium implants coated with peri-apatite in rabbit femoral defect. J Biomed Mater Res B Appl Biomater. 2004;71:408\u201313.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"229_CR30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/jbm.a.30151","volume":"71","author":"R Zhang","year":"2004","unstructured":"Zhang R, Xu D, Landeryou T, et al. Ectopic bone formation using osteogenic protein-1 carried by a solution precipitated hydroxyapatite. J Biomed Mater Res A. 2004;71:412\u20138.","journal-title":"J Biomed Mater Res A"},{"key":"229_CR31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0142-9612(01)00134-X","volume":"23","author":"PH Wooley","year":"2002","unstructured":"Wooley PH, Morren R, Andary J, et al. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials. 2002;23:517\u201326.","journal-title":"Biomaterials"},{"key":"229_CR32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/03009740410005944","volume":"33","author":"WP Ren","year":"2004","unstructured":"Ren WP, Yang S, Wooley PH. A novel murine model of orthopaedic wear debris-associated osteolysis. Scand J Rheumatol. 2004;33:349\u201357.","journal-title":"Scand J Rheumatol"},{"key":"229_CR33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1302\/0301-620X.78B1.0780032","volume":"78","author":"M Allen","year":"1996","unstructured":"Allen M, Brett F, Millett P, Rushton N. The effects of particulate polyethylene at a weight-bearing bone-implant interface A study in rats. J Bone Joint Surg Br. 1996;78:32\u20137.","journal-title":"J Bone Joint Surg Br"},{"key":"229_CR34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jcp.2005.027458","volume":"59","author":"L Morawietz","year":"2006","unstructured":"Morawietz L, Classen RA, Schroder JH, et al. Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol. 2006;59:591\u20137.","journal-title":"J Clin Pathol"},{"key":"229_CR35","first-page":"319","volume":"9","author":"N al Saffar","year":"1999","unstructured":"al Saffar N, Revell PA. Pathology of the bone-implant interfaces. J Long Term Eff Med Implants. 1999;9:319\u201347.","journal-title":"J Long Term Eff Med Implants"},{"key":"229_CR36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/(SICI)1097-4636(1999)48:6<889::AID-JBM19>3.0.CO;2-S","volume":"48","author":"LC Jones","year":"1999","unstructured":"Jones LC, Frondoza C, Hungerford DS. Immunohistochemical evaluation of interface membranes from failed cemented and uncemented acetabular components. J Biomed Mater Res. 1999;48:889\u201398.","journal-title":"J Biomed Mater Res"},{"key":"229_CR37","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/S0142-9612(02)00032-7","volume":"23","author":"SY Yang","year":"2002","unstructured":"Yang SY, Ren W, Park Y, et al. Diverse cellular and apoptotic responses to variant shapes of UHMWPE particles in a murine model of inflammation. Biomaterials. 2002;23:3535\u201343.","journal-title":"Biomaterials"},{"key":"229_CR38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2006.04.007","volume":"113","author":"MP Ginebra","year":"2006","unstructured":"Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements as bone drug delivery systems: a review. J Control Release. 2006;113:102\u201310.","journal-title":"J Control Release"},{"issue":"Suppl 2","key":"229_CR39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1469-0691.2008.01924.x","volume":"14","author":"CK Naber","year":"2008","unstructured":"Naber CK. Future strategies for treating Staphylococcus aureus bloodstream infections. Clin Microbiol Infect. 2008;14(Suppl 2):26\u201334.","journal-title":"Clin Microbiol Infect"},{"key":"229_CR40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2004.06.011","volume":"99","author":"M Stigter","year":"2004","unstructured":"Stigter M, Bezemer J, De GK, Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release. 2004;99:127\u201337.","journal-title":"J Control Release"},{"key":"229_CR41","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/S0142-9612(02)00157-6","volume":"23","author":"M Stigter","year":"2002","unstructured":"Stigter M, De GK, Layrolle P. Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. Biomaterials. 2002;23:4143\u201353.","journal-title":"Biomaterials"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-010-0229-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-010-0229-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-010-0229-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T13:49:15Z","timestamp":1558532955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-010-0229-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,6]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["229"],"URL":"https:\/\/doi.org\/10.1007\/s00011-010-0229-x","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,6]]}}}